The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Human Factor VIII Concentrate Market Research Report 2025

Global Human Factor VIII Concentrate Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1736012

No of Pages : 103

Ask Your Query

Synopsis
Complementary therapy for prevention and treatment of hemophilia A acquired coagulation factor Ⅷ deficiency and von Willebrand's disease
Global Human Factor VIII Concentrate market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Human Factor VIII Concentrate market research.
Key manufacturers engaged in the Human Factor VIII Concentrate industry include Pfizer, Novo Nordisk A/S, Shire (Baxter), Bayer, GC Pharma, Shanghai Raas Corp, Hualan Biological, Shandong Taibang Biological Products and Shanghai Xinxing Medicine, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Human Factor VIII Concentrate were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Human Factor VIII Concentrate market and estimated to attract more attentions from industry insiders and investors.

Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Human Factor VIII Concentrate market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • Pfizer
  • Novo Nordisk A/S
  • Shire (Baxter)
  • Bayer
  • GC Pharma
  • Shanghai Raas Corp
  • Hualan Biological
  • Shandong Taibang Biological Products
  • Shanghai Xinxing Medicine
  • SinoCell Tech
  • CSL
  • Grifols
  • Biogen
  • Octapharma
  • NovoNordisk

Segment by Type

  • Blood Extraction
  • Recombine

Segment by Application

  • Congenital Coagulation Factor VIII Deficiency
  • Acquired Factor VIII Deficiency
  • Von Willebrand's Disease

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia) 
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina, Colombia)

The Human Factor VIII Concentrate report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Index

List of Tables
Table 1. Global Human Factor VIII Concentrate Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Human Factor VIII Concentrate Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Human Factor VIII Concentrate Market Competitive Situation by Manufacturers in 2022
Table 4. Global Human Factor VIII Concentrate Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Human Factor VIII Concentrate Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Human Factor VIII Concentrate Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Human Factor VIII Concentrate Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Human Factor VIII Concentrate Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Human Factor VIII Concentrate, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Human Factor VIII Concentrate, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Human Factor VIII Concentrate, Product Type & Application
Table 12. Global Key Manufacturers of Human Factor VIII Concentrate, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Human Factor VIII Concentrate by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Factor VIII Concentrate as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Human Factor VIII Concentrate Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Human Factor VIII Concentrate Sales by Region (2018-2023) & (K Units)
Table 18. Global Human Factor VIII Concentrate Sales Market Share by Region (2018-2023)
Table 19. Global Human Factor VIII Concentrate Sales by Region (2024-2029) & (K Units)
Table 20. Global Human Factor VIII Concentrate Sales Market Share by Region (2024-2029)
Table 21. Global Human Factor VIII Concentrate Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Human Factor VIII Concentrate Revenue Market Share by Region (2018-2023)
Table 23. Global Human Factor VIII Concentrate Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Human Factor VIII Concentrate Revenue Market Share by Region (2024-2029)
Table 25. North America Human Factor VIII Concentrate Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Human Factor VIII Concentrate Sales by Country (2018-2023) & (K Units)
Table 27. North America Human Factor VIII Concentrate Sales by Country (2024-2029) & (K Units)
Table 28. North America Human Factor VIII Concentrate Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Human Factor VIII Concentrate Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Human Factor VIII Concentrate Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Human Factor VIII Concentrate Sales by Country (2018-2023) & (K Units)
Table 32. Europe Human Factor VIII Concentrate Sales by Country (2024-2029) & (K Units)
Table 33. Europe Human Factor VIII Concentrate Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Human Factor VIII Concentrate Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Human Factor VIII Concentrate Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Human Factor VIII Concentrate Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Human Factor VIII Concentrate Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Human Factor VIII Concentrate Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Human Factor VIII Concentrate Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Human Factor VIII Concentrate Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Human Factor VIII Concentrate Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Human Factor VIII Concentrate Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Human Factor VIII Concentrate Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Human Factor VIII Concentrate Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Human Factor VIII Concentrate Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Human Factor VIII Concentrate Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Human Factor VIII Concentrate Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Human Factor VIII Concentrate Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Human Factor VIII Concentrate Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Human Factor VIII Concentrate Sales (K Units) by Type (2018-2023)
Table 51. Global Human Factor VIII Concentrate Sales (K Units) by Type (2024-2029)
Table 52. Global Human Factor VIII Concentrate Sales Market Share by Type (2018-2023)
Table 53. Global Human Factor VIII Concentrate Sales Market Share by Type (2024-2029)
Table 54. Global Human Factor VIII Concentrate Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Human Factor VIII Concentrate Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Human Factor VIII Concentrate Revenue Market Share by Type (2018-2023)
Table 57. Global Human Factor VIII Concentrate Revenue Market Share by Type (2024-2029)
Table 58. Global Human Factor VIII Concentrate Price (US$/Unit) by Type (2018-2023)
Table 59. Global Human Factor VIII Concentrate Price (US$/Unit) by Type (2024-2029)
Table 60. Global Human Factor VIII Concentrate Sales (K Units) by Application (2018-2023)
Table 61. Global Human Factor VIII Concentrate Sales (K Units) by Application (2024-2029)
Table 62. Global Human Factor VIII Concentrate Sales Market Share by Application (2018-2023)
Table 63. Global Human Factor VIII Concentrate Sales Market Share by Application (2024-2029)
Table 64. Global Human Factor VIII Concentrate Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Human Factor VIII Concentrate Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Human Factor VIII Concentrate Revenue Market Share by Application (2018-2023)
Table 67. Global Human Factor VIII Concentrate Revenue Market Share by Application (2024-2029)
Table 68. Global Human Factor VIII Concentrate Price (US$/Unit) by Application (2018-2023)
Table 69. Global Human Factor VIII Concentrate Price (US$/Unit) by Application (2024-2029)
Table 70. Pfizer Corporation Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Human Factor VIII Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Pfizer Human Factor VIII Concentrate Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Novo Nordisk A/S Corporation Information
Table 76. Novo Nordisk A/S Description and Business Overview
Table 77. Novo Nordisk A/S Human Factor VIII Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Novo Nordisk A/S Human Factor VIII Concentrate Product
Table 79. Novo Nordisk A/S Recent Developments/Updates
Table 80. Shire (Baxter) Corporation Information
Table 81. Shire (Baxter) Description and Business Overview
Table 82. Shire (Baxter) Human Factor VIII Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Shire (Baxter) Human Factor VIII Concentrate Product
Table 84. Shire (Baxter) Recent Developments/Updates
Table 85. Bayer Corporation Information
Table 86. Bayer Description and Business Overview
Table 87. Bayer Human Factor VIII Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Bayer Human Factor VIII Concentrate Product
Table 89. Bayer Recent Developments/Updates
Table 90. GC Pharma Corporation Information
Table 91. GC Pharma Description and Business Overview
Table 92. GC Pharma Human Factor VIII Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. GC Pharma Human Factor VIII Concentrate Product
Table 94. GC Pharma Recent Developments/Updates
Table 95. Shanghai Raas Corp Corporation Information
Table 96. Shanghai Raas Corp Description and Business Overview
Table 97. Shanghai Raas Corp Human Factor VIII Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Shanghai Raas Corp Human Factor VIII Concentrate Product
Table 99. Shanghai Raas Corp Recent Developments/Updates
Table 100. Hualan Biological Corporation Information
Table 101. Hualan Biological Description and Business Overview
Table 102. Hualan Biological Human Factor VIII Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Hualan Biological Human Factor VIII Concentrate Product
Table 104. Hualan Biological Recent Developments/Updates
Table 105. Shandong Taibang Biological Products Corporation Information
Table 106. Shandong Taibang Biological Products Description and Business Overview
Table 107. Shandong Taibang Biological Products Human Factor VIII Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Shandong Taibang Biological Products Human Factor VIII Concentrate Product
Table 109. Shandong Taibang Biological Products Recent Developments/Updates
Table 110. Shanghai Xinxing Medicine Corporation Information
Table 111. Shanghai Xinxing Medicine Description and Business Overview
Table 112. Shanghai Xinxing Medicine Human Factor VIII Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Shanghai Xinxing Medicine Human Factor VIII Concentrate Product
Table 114. Shanghai Xinxing Medicine Recent Developments/Updates
Table 115. SinoCell Tech Corporation Information
Table 116. SinoCell Tech Description and Business Overview
Table 117. SinoCell Tech Human Factor VIII Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. SinoCell Tech Human Factor VIII Concentrate Product
Table 119. SinoCell Tech Recent Developments/Updates
Table 120. CSL Corporation Information
Table 121. CSL Description and Business Overview
Table 122. CSL Human Factor VIII Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. CSL Human Factor VIII Concentrate Product
Table 124. CSL Recent Developments/Updates
Table 125. Grifols Corporation Information
Table 126. Grifols Description and Business Overview
Table 127. Grifols Human Factor VIII Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Grifols Human Factor VIII Concentrate Product
Table 129. Grifols Recent Developments/Updates
Table 130. Biogen Corporation Information
Table 131. Biogen Description and Business Overview
Table 132. Biogen Human Factor VIII Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Biogen Human Factor VIII Concentrate Product
Table 134. Biogen Recent Developments/Updates
Table 135. Octapharma Corporation Information
Table 136. Octapharma Description and Business Overview
Table 137. Octapharma Human Factor VIII Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Octapharma Human Factor VIII Concentrate Product
Table 139. Octapharma Recent Developments/Updates
Table 140. NovoNordisk Corporation Information
Table 141. NovoNordisk Description and Business Overview
Table 142. NovoNordisk Human Factor VIII Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. NovoNordisk Human Factor VIII Concentrate Product
Table 144. NovoNordisk Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Human Factor VIII Concentrate Distributors List
Table 148. Human Factor VIII Concentrate Customers List
Table 149. Human Factor VIII Concentrate Market Trends
Table 150. Human Factor VIII Concentrate Market Drivers
Table 151. Human Factor VIII Concentrate Market Challenges
Table 152. Human Factor VIII Concentrate Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Human Factor VIII Concentrate
Figure 2. Global Human Factor VIII Concentrate Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Human Factor VIII Concentrate Market Share by Type in 2022 & 2029
Figure 4. Blood Extraction Product Picture
Figure 5. Recombine Product Picture
Figure 6. Global Human Factor VIII Concentrate Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Human Factor VIII Concentrate Market Share by Application in 2022 & 2029
Figure 8. Congenital Coagulation Factor VIII Deficiency
Figure 9. Acquired Factor VIII Deficiency
Figure 10. Von Willebrand's Disease
Figure 11. Global Human Factor VIII Concentrate Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Human Factor VIII Concentrate Market Size (2018-2029) & (US$ Million)
Figure 13. Global Human Factor VIII Concentrate Sales (2018-2029) & (K Units)
Figure 14. Global Human Factor VIII Concentrate Average Price (US$/Unit) & (2018-2029)
Figure 15. Human Factor VIII Concentrate Report Years Considered
Figure 16. Human Factor VIII Concentrate Sales Share by Manufacturers in 2022
Figure 17. Global Human Factor VIII Concentrate Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Human Factor VIII Concentrate Players: Market Share by Revenue in 2022
Figure 19. Human Factor VIII Concentrate Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Human Factor VIII Concentrate Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Human Factor VIII Concentrate Sales Market Share by Country (2018-2029)
Figure 22. North America Human Factor VIII Concentrate Revenue Market Share by Country (2018-2029)
Figure 23. United States Human Factor VIII Concentrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Human Factor VIII Concentrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Human Factor VIII Concentrate Sales Market Share by Country (2018-2029)
Figure 26. Europe Human Factor VIII Concentrate Revenue Market Share by Country (2018-2029)
Figure 27. Germany Human Factor VIII Concentrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Human Factor VIII Concentrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. Human Factor VIII Concentrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Human Factor VIII Concentrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Human Factor VIII Concentrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Human Factor VIII Concentrate Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Human Factor VIII Concentrate Revenue Market Share by Region (2018-2029)
Figure 34. China Human Factor VIII Concentrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Human Factor VIII Concentrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Human Factor VIII Concentrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Human Factor VIII Concentrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Human Factor VIII Concentrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. China Taiwan Human Factor VIII Concentrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Southeast Asia Human Factor VIII Concentrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Latin America Human Factor VIII Concentrate Sales Market Share by Country (2018-2029)
Figure 42. Latin America Human Factor VIII Concentrate Revenue Market Share by Country (2018-2029)
Figure 43. Mexico Human Factor VIII Concentrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Brazil Human Factor VIII Concentrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Argentina Human Factor VIII Concentrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa Human Factor VIII Concentrate Sales Market Share by Country (2018-2029)
Figure 47. Middle East & Africa Human Factor VIII Concentrate Revenue Market Share by Country (2018-2029)
Figure 48. Turkey Human Factor VIII Concentrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Saudi Arabia Human Factor VIII Concentrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. UAE Human Factor VIII Concentrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Global Sales Market Share of Human Factor VIII Concentrate by Type (2018-2029)
Figure 52. Global Revenue Market Share of Human Factor VIII Concentrate by Type (2018-2029)
Figure 53. Global Human Factor VIII Concentrate Price (US$/Unit) by Type (2018-2029)
Figure 54. Global Sales Market Share of Human Factor VIII Concentrate by Application (2018-2029)
Figure 55. Global Revenue Market Share of Human Factor VIII Concentrate by Application (2018-2029)
Figure 56. Global Human Factor VIII Concentrate Price (US$/Unit) by Application (2018-2029)
Figure 57. Human Factor VIII Concentrate Value Chain
Figure 58. Human Factor VIII Concentrate Production Process
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Distributors Profiles
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock